Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
99 hedge funds and large institutions have $484M invested in Epizyme, Inc in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 21 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
76% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 21
9% more funds holding
Funds holding: 91 → 99 (+8)
13% less capital invested
Capital invested by funds: $559M → $484M (-$74.6M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
55% less call options, than puts
Call options by funds: $20K | Put options by funds: $44K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$7.08M |
| 2 |
DM
Deerfield Management
New York
|
+$6.94M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.43M |
| 4 |
Millennium Management
New York
|
+$2.28M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$9.41M |
| 2 |
QF
QVT Financial
New York
|
-$2.33M |
| 3 |
OPPM
Opus Point Partners Management
New York
|
-$2.3M |
| 4 |
CC
Casdin Capital
New York
|
-$2.29M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.19M |
EPZM Hedge Fund Activity: Q2 2016 in Review
99 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2016, worth a combined $484M — down 13% from $559M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new EPZM positions and 9 closed out — a net gain of 8 holders — while 37 added to existing stakes and 21 trimmed.
The largest buyer was CQS Cayman, opening a new position worth an estimated $7.08M. The largest seller was EcoR1 Capital, cutting an estimated $9.41M.
- 99 institutional investors held Epizyme, Inc (EPZM) as of Q2 2016, up from 91 in Q1 2016.
- Funds reported $484M of Epizyme, Inc stock for Q2 2016, down 13% quarter-over-quarter.
- 17 funds opened new Epizyme, Inc positions in Q2 2016 and 9 closed out, a net change of +8 holders.
- The largest Epizyme, Inc buyer in Q2 2016 was CQS Cayman, an estimated $7.08M added.
- The largest Epizyme, Inc seller in Q2 2016 was EcoR1 Capital, an estimated $9.41M sold.
Based on aggregated 13F filings for Q2 2016.